FAHIM RAAFAT E F 4
4 · NABI BIOPHARMACEUTICALS · Filed Dec 20, 2004
Insider Transaction Report
Form 4
FAHIM RAAFAT E F
DirectorPresident, CEO and CFO
Transactions
- Other
Common Stock
[F1]2004-11-30$12.30/sh+569.106$7,000→ 2,630.676 total
Footnotes (1)
- [F1]Voluntarily reported acquisition under the issuer's 2000 Employee Stock Purchase Plan, which is an exempt transaction pursuant to Rule 16b-3(c).
Signature
/s/ James E. Dawson, as attorney-in-fact|2004-12-20